Metropolitan Life Insurance Company (MetLife)’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio ASPX Stock Details ASPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-8,049	Closed	-$807K	–	2745
2015 Q1	$807K	Hold	8,049	–	–	0.01%	1325
2014 Q4	$422K	Hold	8,049	–	–	﹤0.01%	1884
2014 Q3	$207K	Buy	+8,049	New	+$171K	﹤0.01%	2345
2014 Q2	–	Sell	-9,745	Closed	-$300K	–	2845
2014 Q1	$300K	Buy	+9,745	New	+$262K	﹤0.01%	2175

Metropolitan Life Insurance Company (MetLife)'s ASPX Position: Q2 2015 in Review

Metropolitan Life Insurance Company (MetLife) sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 8,049 shares — an estimated $807K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ASPX in Q1 2014 and held it in 4 quarters. The position peaked at $807K in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

Metropolitan Life Insurance Company (MetLife) reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 8,049 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $807K.
Metropolitan Life Insurance Company (MetLife) first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2014 and held it in 4 quarters.
Metropolitan Life Insurance Company (MetLife)'s AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $807K in Q1 2015.
0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2015, filed 17 Aug 2015.